Beyond Inheritance
Inherexia is building the reasoning layer between the genome and the decisions that shape a family's future.
For most of history, inheritance has been left to chance. We're building the interpretation engine that turns raw genomic data into clear, auditable, evidence-traced insight: so reproductive decisions can be made with understanding instead of uncertainty.
From inheritance to intention
Two people carry, between them, the genetic blueprint of every child they might have. Today, understanding what that blueprint means. Which risks are real, which are uncertain, and what it implies for a future pregnancy— is fragmented, manual, and often inaccessible.
Inherexia is building a deterministic genomic interpretation engine that reasons across both parents' genomes to identify inherited risk, with every conclusion traceable to its underlying evidence. We start where the science is strongest. We are building outward toward a complete picture of reproductive genomic risk.
Our defining principle is restraint: a system trusted in medicine is one that knows the limits of what it can claim. Inherexia is designed to say clearly what the evidence supports, what it does not, and where a human expert must decide.
The Inherexia Engine
A genomic reasoning framework built on a simple commitment: never invent biology, never overclaim, and make every step inspectable.
Evidence-first interpretation
Every finding traces to a versioned source and the scientific literature. Nothing is asserted without provenance.
Couple-level reasoning
Inherexia interprets both parents together, not in isolation, but by identifying shared inherited risk and the Mendelian implications for a future pregnancy.
Auditable by design
The engine exposes its full reasoning chain— from variant, to evidence, to disease association, to inheritance, to interpretation. So a clinician can follow, question, and challenge every conclusion.
Honest about uncertainty
Where evidence is insufficient, Inherexia withholds rather than guesses. It distinguishes reported clinical significance from its own independent assessment, and a non-finding from an absence of risk.
Built and validated on real genomic data, with scientific guidance from clinical genomics experts.
The Inherexia Framework
A staged genomic intelligence framework grounded in today's clinical science, building toward a fuller picture of reproductive risk.
Parental Genome Interpretation
Inherexia ingests both parents' sequencing data and interprets it against curated clinical evidence, identifying carrier status for inherited conditions.
Couple Reproductive Risk
The engine reasons across both genomes to identify shared inherited conditions and the Mendelian probability of risk to a future pregnancy with clear, clinician-ready reporting.
Clinician-Ready Insight
Structured, auditable reports designed to integrate into reproductive care from risk identification to informed genetic counselling.
Toward a Fuller Picture
Long-term research explores broader genomic risk, extending beyond single-gene conditions toward polygenic understanding. Within a strict ethical framework, and always as decision support, never a substitute for human judgment or conscience.
Research
Inherexia is built on published science and validated against real genomic data. Our work is guided by clinical genomics and bioinformatics experts, and grounded in the standards of the field. ACMG interpretation guidelines, ClinGen expert-panel curations, and GA4GH data standards.
We are actively developing the deeper layers of the engine: richer evidence integration, population-specific interpretation for underserved genomic backgrounds, and the biological reasoning that connects a variant to its mechanism and clinical meaning.
We're in ongoing dialogue with clinical and research institutions to validate Inherexia toward real-world use.
Ethics
Reproductive genomics is among the most consequential and sensitive domains in medicine. We treat that responsibility as central, not peripheral.
Inherexia is decision-support, not decision-making. It informs; it does not prescribe. It is built to surface what the evidence shows and, just as importantly, what it cannot. So that choice always remains with families and their clinicians, and never overrides conscience.
We are committed to transparency, auditability, data privacy, and to advancing this technology within the regulatory and ethical frameworks that reproductive medicine demands.
Explore the future with us
Ready to explore the future of reproductive genomics? For partnerships, research collaborations, or clinical inquiries- get in touch.
swapnil@inherexia.com swapnil22523@iiitd.ac.in